Why are doctors and scientists so excited about stem cells?
Stem cells have potential in many different areas of health and medical research.
Adult and embryonic stem cells differ in the type of cells that they can develop into embryonic stem cells can become all cell types of the body (they arepluripotent). Adult stem cells are found in mature tissues (bone marrow, skin, brain, etc.) and give rise to other cell types from their tissue or origin (they are are multipotent). For example, adult blood stem cells give rise to red blood cells, white blood cells and platelets.
Adult stem cells are thought to exist in every type of tissue in the body. But, to date, the isolation of many types of adult stem cells has been limited. Hematopoietic (blood) stem cells are readily available via bone marrow aspiration. But stem cells for solid organs such as liver or brain have proven more difficult to identify and derive. The hope is that hESCs can be used to derive every type of adult stem cell in the body and allow research that is currently not possible.
Embryonic stem cells are isolated from 3 to 5 day old human embryos at the blastocyst stage. The blastocyst is a hollow microscopic cluster of several hundred undifferentiated cells.
This is a culture of hESCs derived from a single embryo. Because stem cells can self-replicate, just a few hESCs can give rise to a whole population of identical hESCs, or a cell line.
Once established, a cell line can be grown in the laboratory indefinitely and cells may be frozen for later use or distributed to other researchers. Because each cell line has its own distinct genetic footprint, researchers are often interested in using the same cell line for a number of related experiments.
No. At this point, the promise is huge, but hESC research is still in its early stages. Human embryonic stem cell (hESC) research only began in 1998, when a group led by Dr. James Thomson at the University of Wisconsin developed a technique to isolate and grow the cells.
In late January 2009, the California-based company Geron received FDA clearance to begin the first human clinical trial of cells derived from human embryonic stem cells.
In contrast, research with adult stem cells such as blood-forming stem cells in bone marrow (called hematopoietic stem cells, or HSCs) has been active for over decades. And this research has resulted in treatment of patients; for example, bone marrow (stem cell) transplants have been conducted for over 40 years.
In addition, studies with a limited number of patients have demonstrated the clinical potential of adult stem cells in the treatment of other human diseases that include diabetes and advanced kidney cancer.
Induced pluripotent stem cells (iPS cells) are cells that began as normal adult cells (for example, a skin cell) and were engineered (induced) by scientists to become pluripotent, that is, able to form all cell types of the body. This process is often called 'reprogramming.' While iPS cells and embryonic stem cells share many characteristics they are not identical. Scientists are currently exploring whether they differ in clinically significant ways.
The technology used to generate iPS cells holds great promise for creating patient- and disease-specific cell lines for research purposes. These cells are already useful tools for drug development and scientists hope to use them in transplantation medicine. However, additional research is needed before the reprogramming techniques can be used to generate stem cells suitable for safe and effective therapies.
Somatic cell nuclear transfer (SCNT), is a technique in which the nucleus of a somatic cell (any cell of the body except sperm and egg cells) is injected, or transplanted, into an egg, that has had its nucleus removed. The product of SCNT has the same genetic material as the somatic cell donor.
Yes. SCNT is a technique of cloning. The product of SCNT is nearly genetically identical to the somatic cell used in the process. (Of note, the product of SCNT is not technically 100% identical in that the cytoplasm of the oocyte includes mitochondrial DNA.) While SCNT is considered cloning, it is important to differentiate between therapeutic and reproductive cloning. The following FAQ addresses these differences.
Reproductive cloning includes the placement of the product of SCNT into a uterus for the purpose of a live birth. The resulting organism would, in theory, be the genetic copy of the somatic cell donor. Reproductive cloning has been performed in animals for many years and is burdened by many technical and biological problems. Only about 1 percent of all the eggs that receive donor DNA can develop into normal surviving clones. Therapeutic cloning uses SCNT for the sole purpose of deriving cells for research, and potentially in the future for therapy. In therapeutic cloning, the product of SCNT is not placed into a uterus and hence a live birth is never a possibility. Therapeutic cloning provides two potential benefits.
Yes. Massachusetts state law that was enacted in May 2005 allows hESC research and it allows the derivation of hESCs from embryos that were created for reproductive purposes and are no longer needed for reproduction and from somatic cell nuclear transfer.
The National Academy of Sciences (NAS) issued guidelines for hESC research in April 2005, and subsequently updated those guidelines in 2007 and 2008. The current guidelines contain detailed recommendations with regard to many aspects of hESC research, including:
No. IRB approval is required for:
Until recently, the federal government limited its funding to specific hESCs derived before August 9, 2001. Specifically, federal funds were only allowed for research on hESCs listed on the National Institutes of Health (NIH) Registry, and on derivative products from hESCs on the NIH Registry. On March 9, 2009, President Obama signed an executive order clearing the way for the NIH and other federal agencies to fund research using all kinds of hESCs.
Human embryonic stem cell research at the Center for Regenerative Medicine has been supportedin partby private philanthropic donations. These donations allowed us to support a wide range of research activities that could not have been supported from other sources such as NIH funding. In the future, we expect to receive support for eligible activities from NIH and other funding agencies.
The Center for Regenerative Medicine depends upon philanthropic support. To find out how you can help accelerate research and discovery, please click here.
The Center for Regenerative Medicine is dedicated to understanding how tissues are formed and may be repaired in settings of injury. Embedded at Mass General Hospital, the Center's primary goal is to develop novel therapies to regenerate damaged tissues and thereby overcome debilitating chronic disease. The success of this effort requires a cohesive team of scientists and clinicians with diverse areas of expertise, but with a shared mission and dedication to the larger goal.
The Center for Regenerative Medicine has extensive interactions with other investigators at MGH and in the broader Harvard-MIT community. The Center helped galvanize the establishment of the Harvard Stem Cell Institute (HSCI), which is co-directed by Dr. Scadden and Dr. Douglas Melton of Harvard's Department of Stem Cell and Regenerative Biology and the Howard Hughes Medical Institute. As an important confederated partner of HSCI, the Center brings specific features that augment other elements of HSCI, including unique stem cell clinical investigation expertise and ongoing collaborative clinical trials using stem cell transplantation. The Center emphasizes technologies that will ultimately be critical for the success of stem cell based medicine, including bioengineering, biomaterials expertise, close links to in vivo imaging capability and its GMP facility for sophisticated cell manipulation.
Read the original here:
Stem Cell FAQ - Massachusetts General Hospital, Boston, MA
- Justin Thomas, Danny Lee tied for 3rd-round lead at CJ Cup - Sports and Weather Right Now - October 21st, 2019
- Infanticide in US Abortion Mills - Church Militant - October 19th, 2019
- Sunny days and chilly nights this weekend - WMTW Portland - October 19th, 2019
- 3 siblings with rare, life-threatening blood disorder in need of bone marrow transplants CNN - WBAL Baltimore - October 19th, 2019
- Storms expected to finish the weekend - KCCI Des Moines - October 19th, 2019
- Update on the latest sports - FOX5 Las Vegas - October 19th, 2019
- Selma Blair Went Through Chemotherapy for MS Treatment and Was Told to Make Plans for Death - Parade - October 19th, 2019
- How Young India is fuelling the future of stem cell therapy and signing up to save lives - YourStory - October 19th, 2019
- Clinic helps women have babies after cancer - WNDU-TV - October 19th, 2019
- Holy Name clinical trial tests the healing power of stem cells - NJTV News - October 19th, 2019
- Fit and healthy teacher dies 20 days after discovering he had leukaemia at 33 - The Sun - October 19th, 2019
- Eurecon Verlag GmbH: 20th Pharma Trend Image & Innovation Awards The Winners and Runner-ups - BioSpace - October 10th, 2019
- World Cord Blood Day 2019 to Welcome Leading Transplant Doctors and Pioneering Cellular Therapy Researchers - PRNewswire - October 10th, 2019
- Sarah Ferguson admits shes had Botox, TWO types of facelift and vitamin injections in a bid to stay youthful - The Sun - October 10th, 2019
- A Doctor Plumbs The Depths Of Ivan Doig's Illness And Asks: 'Did He Have An Epiphany?' - Mountain Journal - October 10th, 2019
- Campaign to save five-year-old cancer sufferer has become one of the fastest online charity appeals EVER - The Sun - October 10th, 2019
- Six people with links to UCLH listed among most influential people in London - University College London Hospitals - October 10th, 2019
- WWE Hall Of Famer Edge returning to the ring? - Wrestling News - October 4th, 2019
- Out of this world: Zionsville doctor sends osteoblast cells into space to study drug effects - Current in Carmel - October 4th, 2019
- Digital health, Unicorns and what the smart money is chasing - BizNews - October 4th, 2019
- Leesport boy fighting a second battle with cancer - Reading Eagle - October 3rd, 2019
- Man with terminal cancer battles back from coma to marry his childhood sweetheart - Mirror Online - October 3rd, 2019
- 2 Years Later, Retired Toms River Teacher Meets Bone Marrow Donor - wobm.com - October 3rd, 2019
- March to fight multiple myeloma scheduled this weekend - BlackburnNews.com - October 2nd, 2019
- Middlesbrough blood donor meets man she saved in Germany - The Northern Echo - October 2nd, 2019
- Taz Believes CM Punk Will Be At SmackDown On Fox Thinks Edge Could Pop Up On AEW Or SmackDown - Fightful - October 2nd, 2019
- Kevin Mwachiro: Keeper of Stories - Roads and Kingdoms - October 2nd, 2019
- Mansfield's Daniel Maberry has returned to coaching during battle with cancer, but his stay on sideline will be brief - The Dallas Morning News - September 25th, 2019
- Eyes on the Prize: The CBC Fights Blindness During Sickle Cell Awareness Month - The Root - September 25th, 2019
- What's on TV Monday: The season premiere of 'Bull' on CBS - Los Angeles Times - September 25th, 2019
- Rheumatoid Arthritis Stem Cell Therapy Market Excessive Growth Opportunities Estimated to be Experienced 2018 to 2028 - Commerce Gazette - September 25th, 2019
- Forecasting the Future of Medicine - The Future of Things - September 25th, 2019
- 'My blood brother:' Bone marrow donation started a friendship - Ottawa Citizen - September 25th, 2019
- Abortion Foe Defends Secret Taping as Investigative Work - Courthouse News Service - September 22nd, 2019
- Cancer is 'only a word,' says Moncton city councillor diagnosed with multiple myeloma - CBC.ca - September 22nd, 2019
- Avoidable blindness: making global sight loss a thing of the past - Raconteur - September 22nd, 2019
- I turned down chemo after being diagnosed with terminal cancer and lived then I became pregnant after d - The Sun - September 22nd, 2019
- Football Players? Or Lab Rats Who Can Run and Pass? - The New York Times - September 22nd, 2019
- Daleiden: sworn testimony exposed Planned Parenthoods crime of trafficking aborted-baby body-parts - Lifesite - September 22nd, 2019
- Mum's tireless campaign as daughter, 2, is kept alive by blood donors - Yahoo News Australia - September 22nd, 2019
- 3-day blood drive in Bathurst supports toddler with rare disease - CBC.ca - September 22nd, 2019
- Bone marrow donor from Germany becomes recipient's maid of honour - DNA India - September 22nd, 2019
- Tumor Marker Testing Market Size, Growth, Trends and 2023 Forecast Report - OnYourDesks - September 22nd, 2019
- Im pleading with you please donate blood to help save my baby girl without it shell die - The Sun - September 22nd, 2019
- Tecumseh girl still looking for bone marrow donor - BlackburnNews.com - September 22nd, 2019
- Cell Harvesting Systems Market research to Exhibit Significant Incremental Dollar Opportunity During the Forecast Period 2016-2026 - Analytics News - September 22nd, 2019
- Leukemia: Know the risk factors to keep the disease at bay - TheHealthSite - September 22nd, 2019
- NI teen's devastating cancer diagnosis days after dream Taylor Swift trip - Belfast Live - September 22nd, 2019
- Buy PRP Kits & Stem Cell Therapy Supplies for Regenerative ... - May 21st, 2019
- LifeCell - India's First and Largest Stem Cell Bank - May 21st, 2019
- Stem Cell Doctors in Auburn Novi MI| Chronic knee pain doctors in Auburn Novi - May 15th, 2019
- Doctors used stem cells to treat stroke symptoms ... - May 15th, 2019
- Elite Hospitals Plunge Into Unproven Stem Cell Treatments ... - May 12th, 2019
- Adult Stem Cell Success Story | Spinal Cord Injury | SCRF - May 12th, 2019
- Best Stem Cell Doctors in Plymouth | Stem cell hip Regeneration Hip Doctor Plymouth MI - May 4th, 2019
- Stem Cell Therapy | New York - Park Avenue Stem Cell - April 15th, 2019
- Ask the doctors: Stem cell therapies need more research ... - April 13th, 2019
- stem cell Doctors in Dearborn | stem cell knee injections in Dearborn - April 13th, 2019
- Sports & Regenerative Medicine Specialist, Stem Cell ... - April 13th, 2019
- Stem Cell Doctors in Delaware, Stem cell injections, Stem ... - April 13th, 2019
- Meet Our Doctors | National Stem Cell Centers | NY Stem ... - April 13th, 2019
- Stem Cell Doctors | Regenerative Medicine | Stem Cell ... - March 7th, 2019
- 2nd ever HIV patient in remission after stem cell ... - March 7th, 2019
- Stem Cell Docu Series - March 5th, 2019
- Dr. Neil Riordan, Cell Therapy Expert - Stem Cell Treatment ... - February 24th, 2019
- Stem Cell Therapy Tulsa OK | Broken Arrow | Jenks - February 24th, 2019
- Stem Cell Knee Therapy Cost | Stem Cell Knee Injection ... - February 17th, 2019
- Stem Cell Transplantation | Leukemia and Lymphoma Society - February 17th, 2019
- Oregon Regenerative Medicine - Advanced Joint and Injury ... - February 17th, 2019
- Bone marrow transplant - Mayo Clinic - February 17th, 2019
- Stem Cell Therapy Sarasota | Advanced Rejuventation - February 17th, 2019
- Stem Cell for Lower Back Pain Specialists Tombal TX | The Best Stem Cell Doctors in Tombal TX - February 17th, 2019
- Regenerative Medicine Uses And Future Potential ... - February 17th, 2019
- Stem cell Doctors Auburn Hills MI | knee pain treatment Auburn Hills MI - February 15th, 2019
- Stem cell Doctors Troy MI | knee pain treatment Troy MI - February 15th, 2019
- Stem Cell Fraud: A 60 Minutes investigation - CBS News - February 15th, 2019
- Knee - Regenexx - February 15th, 2019
- stem cell Doctors in Dearborn MI | stem cell clinic Dearborn - January 7th, 2019
- Stem Cell of Atlanta Regenerative Stem Cell Therapy ... - December 15th, 2018
- South Texas Spinal Clinic: Orthopedic Surgeons: South Texas - December 15th, 2018